In connection with the implementation of the project entitled ‘Design and development of nanoparticle RNA based drugs to be used in anti-cancer therapy with the construction of a nanoparticle platform for targeted delivery of therapeutic nucleic acids’, by Biotechna SA, within the framework of agreement no. 2022/ABM/06/00005-00 for the co-financing of the Commercial Project within the framework of the Competition for the development of targeted or personalised medicine based on
therapeutic products based on nucleic acids and small-molecule compounds, the Ordering Party is making a market survey concerning the costs of purchase and delivery NCI-H1623 cell lines.
In order to submit an offer, please read the detailed content of the announcement in the request for quotation 56/2025 and send the completed offer form.